Oppenheimer analyst Esther Rajavelu lowered the price target on Kempharm (NASDAQ: KMPH) to $8.00 (from $10.00) while maintaining a Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE